Targeted drug conjugates in cancer therapy: Challenges and opportunities

Jia, Geng; Jiang, Yuqi; Li, Xiaoyang

doi:10.1016/j.pscia.2024.100048

Pharmaceutical Science Advances

2024

DOI: 10.1016/j.pscia.2024.100048

|View full text |Cite

Targeted drug conjugates in cancer therapy: Challenges and opportunities

Geng Jia,

Yuqi Jiang,

Xiaoyang Li

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 211 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Liu,

Zhang,

Zhang

et al. 2024

Chemistry & Biodiversity

View full text Add to dashboard Cite

The discovery and development of efficient VEGFR‐2 inhibitors has become a research hotspot in cancer treatment. In this work, a series of new benzofuran‐based chalcone derivatives have been prepared, and in vitro anticancer activities have been evaluated. The results revealed that derivatives showed selective cytotoxic activity against HCC1806, Hela and A549 cell lines, especially 5c exhibited excellent inhibitory effect on VEFGR‐2 (IC50 = 1.07 nM). The molecular docking study indicated that 5c had an obvious binding site with the target VEGFR‐2 (PDB ID: 4BSK). Therefore, the benzofuran‐based chalcone derivatives could be potent VEGFR‐2 inhibitors.

show abstract

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Liu,

Zhang,

Zhang

et al. 2024

Chemistry & Biodiversity

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Targeted drug conjugates in cancer therapy: Challenges and opportunities

Cited by 1 publication

References 211 publications

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Contact Info

Product

Resources

About